- Home
- IMVT vs VICR Comparison
IMVT vs VICR Comparison
Compare IMVT & VICR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- VICR
- Stock Information
- Founded
- IMVT 2018
- VICR 1981
- Country
- IMVT United States
- VICR United States
- Employees
- IMVT N/A
- VICR N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- VICR Industrial Machinery/Components
- Sector
- IMVT Health Care
- VICR Technology
- Exchange
- IMVT Nasdaq
- VICR Nasdaq
- Market Cap
- IMVT 2.7B
- VICR 2.3B
- IPO Year
- IMVT N/A
- VICR N/A
- Fundamental
- Price
- IMVT $16.16
- VICR $50.77
- Analyst Decision
- IMVT Buy
- VICR Hold
- Analyst Count
- IMVT 11
- VICR 2
- Target Price
- IMVT $33.88
- VICR $43.00
- AVG Volume (30 Days)
- IMVT 1.5M
- VICR 305.2K
- Earning Date
- IMVT 11-06-2025
- VICR 10-21-2025
- Dividend Yield
- IMVT N/A
- VICR N/A
- EPS Growth
- IMVT N/A
- VICR 576.06
- EPS
- IMVT N/A
- VICR 1.45
- Revenue
- IMVT N/A
- VICR $379,346,000.00
- Revenue This Year
- IMVT N/A
- VICR $20.25
- Revenue Next Year
- IMVT N/A
- VICR $4.82
- P/E Ratio
- IMVT N/A
- VICR $35.25
- Revenue Growth
- IMVT N/A
- VICR 2.46
- 52 Week Low
- IMVT $12.72
- VICR $35.41
- 52 Week High
- IMVT $32.10
- VICR $65.70
- Technical
- Relative Strength Index (RSI)
- IMVT 51.87
- VICR 55.73
- Support Level
- IMVT $16.08
- VICR $49.36
- Resistance Level
- IMVT $17.20
- VICR $51.38
- Average True Range (ATR)
- IMVT 0.77
- VICR 1.35
- MACD
- IMVT 0.16
- VICR -0.13
- Stochastic Oscillator
- IMVT 58.68
- VICR 40.95
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.